Αρχική World News New on NCI’s Websites for December 2020

New on NCI’s Websites for December 2020

, by NCI Staff

Imaging Data Commons

NCI’s collection of cancer information products is constantly growing, so we provide periodic updates on new and updated content of interest to the cancer community.

Imaging Data Commons

The NCI Cancer Research Data Commons has launched its newest repository, the Imaging Data Commons (IDC). The IDC provides imaging data, metadata, and an open library of tools for high performance computation and analysis. It currently includes radiological imaging data from The Cancer Imaging Archive; future phases will draw in pathology data and collections from other NCI data coordinating centers.  

Emotional Support for Young People with Cancer

This new resource from NCI can help young people find support after a cancer diagnosis and during cancer treatment. It includes advice on talking with mental health experts, spotting signs of depression, and finding support groups.

Cancer Disparities

This revised page on cancer disparities addresses disparities seen in population groups defined by race/ethnicity as well as other factors. It also now defines health equity and explains how the interplay between the social determinants of health, environment, behavior, biology, and genetics can affect health.

Evidence-Based Cancer Control Programs Website

NCI’s Division of Cancer Control and Population Sciences has relaunched its Research-Tested Intervention Programs (RTIPs) website as the Evidence-Based Cancer Control Programs (EBCCP) website. The EBCCP website is a searchable database of evidence-based cancer control programs and is designed to provide program planners and public health practitioners easy and immediate access to program materials. The team engaged with program planners and public health practitioners for feedback to help enhance the functionality of the website. Visitors to the EBCCP website can stay informed by subscribing to the EBCCP Connection newsletter.

NCI Launches the Cancer Moonshot℠ Biobank

NCI’s Division of Cancer Treatment and Diagnosis (DCTD) has launched the Cancer Moonshot Biobank, a 5-year project to learn more about cancer with the help of participants who donate blood and tissue samples as they receive treatment. The biobank works with patients and their medical providers to donate biospecimens over time and distribute the biospecimens and associated data to qualified researchers.

DCEG Linkage Newsletter: Fall 2020 Issue

The Division of Cancer Epidemiology and Genetics (DCEG) has published the fall 2020 issue of its e-newsletter, Linkage. This issue includes an in-depth profile of the Biostatistics Branch, an update on COVID research in DCEG by Clinical Director Sharon Savage, the division’s latest research highlights, insights into the training experience at DCEG, and staff updates and activities.

Initial Screening Phase Molecular Analysis Results from NCI-MATCH

The molecular results of the initial screening phase of the Molecular Analysis for Therapy Choice (NCI-MATCH) clinical trial are now available on DCTD’s website. The results were originally published in October by the Journal of Clinical Oncology.

New Issue of OCG e-Newsletter

The Office of Cancer Genomics (OCG) has published issue 24 of its e-newsletter. This issue highlights a genomic study of cervical cancers in Ugandan patients; the University of California, San Francisco’s Immunoprofiler Consortiumnext-generation cancer models and data available via the Genomic Data Commons; and Cancer Target Discovery and Development Network clinical trials and includes a perspective article by Julyann Pérez-Mayoral, Ph.D., the new program manager of the Human Cancer Models Initiative.

Video—Testicular Cancer | Did You Know?

Testicular cancer is most frequently diagnosed among men aged 20–34. The updated Testicular Cancer | Did You Know? video features facts and statistics on testicular cancer incidence and survival trends.

Resource for Young People Facing End-of-Life Decisions

A new resource from NCI includes tips to help young people facing end-of-life decisions talk with their doctors and make choices about palliative care, advance directives, living wills, and how they want to be remembered.

BRCA Gene Mutations: Cancer Risk and Genetic Testing

People who inherit harmful variants of the BRCA1 or BRCA2 gene have a higher risk of several cancers. This updated fact sheet describes the types of cancer linked to these mutations and information about genetic counseling and testing.

NCI News Release—Study of “Exceptional Responders” Yields Clues to Cancer and Treatment

In a comprehensive analysis of patients with cancer who had unexpected and long-lasting responses to therapy, researchers have identified molecular changes in the patients’ tumors that may explain some of the exceptional responses.

NCI News Release—Some Postmenopausal Women with Breast Cancer May Forgo Chemotherapy

Findings from a clinical trial presented at the 2020 San Antonio Breast Cancer Symposium may save tens of thousands of postmenopausal women each year the time, money, and harmful side effects that come with chemotherapy infusions.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...
- Advertisment -

Ροή Ειδήσεων

Final Results of the Collaborative EORTC/Intergroup Randomised Phase III Study of Adjuvant Imatinib in Localised GIST

Final analysis of the EORTC Soft Tissue and Bone Sarcoma Group, the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and...

Pink Van Makes the Rounds Throughout Rural New Zealand to Offer Free Breast Health Advice

Many of us have questions about breast cancer prevention or screenings. Getting lost in a Google rabbit hole can sometimes be overwhelming and could...

How My Inherited Cancer Diagnosis Has Made Me a Better Oncologist

Dr. Lewis is Director of Gastrointestinal Oncology at Intermountain Healthcare Utah; Vice President of American Multiple Endocrine Neoplasia Support; Head of the Communications Committee...

FDA Approves Cemiplimab-rwlc for Advanced Non-Small Cell Lung Cancer With High PD-L1 Expression

On 22 February 2021, the US Food and Drug Administration (FDA) approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) for the first-line treatment of patients with...

Five-Year Outcomes with CAR T Cell Therapy

The results of 5-year follow-up in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma who were treated with CD19-directed,...

Countdown to 100,000 OncoLife Survivorship Care Plans: How it all started

In April of 2007, OncoLink launched the OncoLife Survivorship Care Plan, a tool to create care plans for people who have survived cancer. As...